Goldman Sachs raised the firm’s price target on Imax (IMAX) to $18 from $17 and keeps a Sell rating on the shares. The firm notes the company reported Q2 results that were inline with consensus on Revenue and slightly above on company reported Adjusted EBITDA driven by operating leverage on higher revenues and continued execution against cost efficiencies.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Imax price target raised to $38 from $31 at Seaport Research
- Imax price target raised to $37 from $35 at Rosenblatt
- IMAX Corporation Reports Strong Q2 2025 Results
- IMAX Earnings Call Highlights Record Growth and Optimism
- IMAX’s Strong Market Position and Growth Prospects Justify Buy Rating and Raised Price Target